- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Fr | Winnebago Industries, Inc.: Winnebago Industries Reports First Quarter Fiscal 2025 Results | 94 | -- Overall Performance Reflects Challenging Outdoor Recreation Market Environment -- -- Barletta Continues to Expand U.S. Aluminum Pontoon Market Share, Driving Growth of Marine Segment... ► Artikel lesen | ||
| Fr | NCC AB: NCC to fully refurbish five blocks in Aarhus for SEK 1 billion | 226 | NCC has been commissioned by Brabrand Boligforening to fully refurbish five residential blocks in the Gellerup district in Aarhus, Denmark. The order value is approximately SEK 1 billion.
Image:... ► Artikel lesen | ||
| Fr | Eton Pharmaceuticals Closes Acquisition of Increlex (mecasermin injection) | 95 | Acquisition bolsters Eton's commercial pediatric endocrinology portfolioProduct is now available through AnovoRx, a specialty pharmacy dedicated to serving patients with rare and chronic conditions... ► Artikel lesen | ||
| Fr | Auriant Mining AB (publ.) shares to be moved from First North Premier Segment to Nasdaq First North Growth Market | 75 | Auriant Mining AB (the "Company") has been informed by the Exchange that its shares (AUR, ISIN code SE0001337213) will be moved from the First North Premier Segment to Nasdaq First North Growth Market.... ► Artikel lesen | ||
| Fr | Foresight Autonomous Holdings Ltd.: Eye-Net and SoftBank Join Forces with Japanese Automaker to Advance Cellular V2X Technology for Enhanced Road Safety | 148 | Ness Ziona, Israel, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) ("Foresight" or the "Company"), an innovator in 3D perception systems, announced that... ► Artikel lesen | ||
| Fr | Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Announces Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales | 86 | ~ PEDMARQSI® (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ototoxicity (hearing loss) in children and... ► Artikel lesen | ||
| Fr | ROCKWOOL A/S: Completion of conversion of A shares to B shares in accordance with the articles of association and information on adjusted number of voting rights and share capital | 43 | Company announcementfor ROCKWOOL A/SRelease no. 69 - 2024to Nasdaq Copenhagen 20 December 2024 Completion of conversion of A shares to B shares in accordance with the articles of association... ► Artikel lesen | ||
| Fr | Canoo, Inc.: Canoo Inc. Announces 1-for-20 Reverse Stock Split Effective December 24, 2024 | 126 | JUSTIN, Texas, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Canoo Inc. (NASDAQ: GOEV), ("Canoo" or the "Company"), an advanced high-tech mobility company, announced today that it will effect a 1-for-20 reverse... ► Artikel lesen | ||
| Fr | Internet Governance Forum: IGF 2024 Concludes 19th Edition, Calling for Enhanced Digital Cooperation and Sustainable Development | 275 | RIYADH, Saudi Arabia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The Internet Governance Forum (IGF) successfully concluded its 19th edition, hosted in Riyadh at the King Abdulaziz International Conference Center... ► Artikel lesen | ||
| Fr | Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial | 1.590 | Bagsværd, Denmark, 20 December 2024 - Novo Nordisk today announced headline results from REDEFINE 1, a phase 3 trial in the global REDEFINE programme. REDEFINE 1 is a 68-week efficacy and safety trial... ► Artikel lesen | ||
| Fr | Arcario AB Announces Name Change to K33 AB (publ) and Ticker to "K33" | 11 | Arcario AB will change its name to K33 AB (publ) and ticker symbol to "K33", following the resolution passed at the Extraordinary General Meeting on December 13, 2024. This change reflects K33's position... ► Artikel lesen | ||
| Fr | FLSmidth A/S: Proposed changes in the composition of the FLSmidth & Co. A/S Board of Directors | 370 | COMPANY ANNOUNCEMENT NO. 13-2024 20 December 2024, Copenhagen, Denmark
The FLSmidth & Co. A/S Board of Directors announces the following proposed changes to the Board ahead of the Annual General... ► Artikel lesen | ||
| Fr | Ultragenyx Pharmaceutical Inc.: NHS England Rolls Out Evkeeza (evinacumab) for Eligible Adults and Adolescents Aged 12 Years and Older with Homozygous Familial Hypercholesterolaemia (HoFH) | 265 | LONDON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and... ► Artikel lesen | ||
| Fr | Hitachi Energy Ltd: Hitachi Energy wins over 2 billion euro order from Amprion | 305 | Amprion's HVDC project, Korridor B, will transport wind energy from the North Sea coast to the Ruhr Region to provide power to 4 million people -- HVDC Light® technology supports the TSO's strategy... ► Artikel lesen | ||
| Fr | Quadient strengthens its financial position with a USD50 million bank loan from Bank of America | 881 | Quadient strengthens its financial position with a USD50 million bank loan from Bank of America Paris, December 20, 2024 Quadient S.A. (Euronext Paris: QDT), a global automation platform powering... ► Artikel lesen | ||
| Fr | Kenmare Resources: Appointment of Chief Financial Officer | 95 | Kenmare Resources plc("Kenmare" or "the Company" or "the Group") 20 December 2024 Appointment of Chief Financial Officer Kenmare Resources plc (LSE:KMR, ISE:KMR), one of the leading global producers... ► Artikel lesen | ||
| Fr | SPIE SA: SPIE announces the acquisition of AnyLinQ B.V. in The Netherlands | 184 | Cergy, December 20th, 2024 - SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the acquisition of 100% of AnyLinQ B.V. in The Netherlands.... ► Artikel lesen | ||
| Fr | Koninklijke KPN N.V.: KPN announces redemption of Perpetual Hybrid Capital Securities | 78 | Today, Koninklijke KPN N.V. ("KPN") announces the redemption of all of the outstanding € 219,400,000 Perpetual Fixed Rate Resettable Capital Securities issued by KPN on 8 November 2019 (ISIN XS2069101868)... ► Artikel lesen | ||
| Fr | Aktia Bank Plc: Sakari Järvelä appointed Chief Financial Officer at Aktia | 96 | Aktia Bank PlcStock exchange release 20 December 2024 at 8.30 a.m. Sakari Järvelä appointed Chief Financial Officer at Aktia Sakari Järvelä, M.Sc. (Econ), has been appointed Chief Financial Officer... ► Artikel lesen | ||
| Fr | Kitron ASA: Kitron Sweden to expand factory in Jönköping | 200 | (2024-12-20) The expansion of the factory will add approximately 6000 square meters and will be completed during the second half of 2025.
After the expansion, Kitron will have approximately 14000... ► Artikel lesen | ||
| Fr | Nokia Oyj: Nokia and Turkcell Demonstrate Industry Leading Quantum-Safe Protection for Mobile Subscribers | 423 | Press Release
Nokia and Turkcell Demonstrate Industry Leading Quantum-Safe Protection for Mobile Subscribers
Collaborative testing validates secure and trusted quantum-safe IPsec protection... ► Artikel lesen | ||
| Fr | Santhera Pharmaceuticals Holding AG: Santhera Announces Approval in Hong Kong for AGAMREE (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy | 449 | Department of Health (DoH) of Hong Kong approved AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in
patients aged 4 years and older Follows recent approval from China's National... ► Artikel lesen | ||
| Fr | Idorsia Pharmaceuticals Ltd: Idorsia provides update on the exclusive negotiations for the global rights to aprocitentan | 627 | Ad hoc announcement pursuant to Art. 53 LR
Company announces delay to the targeted timeline for signing a binding agreementCompany in discussions with bondholders to restructure the company's outstanding... ► Artikel lesen | ||
| Fr | Cytokinetics, Incorporated: Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China | 200 | SOUTH SAN FRANCISCO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Sanofi will acquire exclusive rights to develop and commercialize aficamten... ► Artikel lesen | ||
| Fr | Humacyte, Inc: Humacyte Announces FDA Approval of SYMVESS (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma | 75 | - SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair - - In clinical testing SYMVESS was observed... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
